02.12.2020 Views

MEDISCOPE | ISSUE 2 | 02 DECEMBER 2020

  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

to survive exposure to the antibiotics that kill

them. Mutations in the genome of bacteria may

cause resistance and are passed on to offspring.

Resistant genes may be in plasmids which can be

transferred to offspring, or they may be directly

inserted into the circular DNA as pathogenicity

islands.

What does antibiotic resistance mean for public

health services?

Antibiotic resistance has become an increasingly

prevalent problem, and by 2050 superbugs could

kill more people than cancer. In the United States

more than 23 000 people die from resistant

bacteria each year.

MRSA is now commonly associated with hospitals.

The over sterile conditions provide the perfect

place for staphylococcus aureus to be exposed to

antibiotics and become resistant to them.

According to the annual epidemiological report by

Public Health England, the all-case rate of MRSA

dropped from 2007/08 to 2018/19 by 7.2 per

100,000 however recently this decline has

stopped: the average rate of MRSA cases has

6

remained stable from 2015 to 2019. The same

observation can be made in the United States. The

CDC saw the rate of MRSA cases decrease by 17.1%

each year from 2005 to 2012. However from 2013

7

to 2016 no significant change was detected.

For public health services antibiotic resistance is a

very significant threat. Many treatments require

the use of antibiotics so that the patient does not

suffer from bacterial infections that could worsen

their condition. For example, those undergoing

chemotherapy are more vulnerable to infection

and require antibiotics. Additionally, the second

major cause of death of those on dialysis

treatment is infection, which makes antibiotics

vital for the patient’s survival. Furthermore those

receiving organ transplants have to take immunosuppressant

drugs which also increase the risk of

infection.

How do we tackle resistant bacteria?

Microbiologists have been using genome

sequencing technology to map the genome of

species of bacteria. This means a mutant resistant

strain can be compared with the existing sequence

of the normal bacteria genome to see exactly

which genes are causing the resistance.

There are also ways of slowing the spread of

antibiotic resistance. The overuse of antibiotics is

one of the major causes of antibiotic resistance.

Therefore healthcare professionals should only

prescribe antibiotics in cases of severe bacterial

infection. Patients should be cautious and finish

the antibiotic course exactly as specified so that

the stronger bacteria do not remain and duplicate.

Viral infections such as influenza do not require

antibiotics.

However there are some causes of antibiotic

resistance that individuals cannot directly control.

For example, in some countries, antibiotics used in

livestock are not regulated and many animals

involved in meat production are overfed

antibiotics. This overuse provides the opportunity

for bacteria to become resistant. However the EU

did introduce regulations in 2006 to stop this

misuse in Europe but there are still many countries

that do not impose laws on this issue.

Bacteriophages

There are one group of non-living organisms that

can destroy bacteria: bacteriophages. They are

viruses that specialise to kill specific types of

bacteria. Up to 40% of bacteria in the ocean are

killed by bacteriophages. They work by inserting

their genetic material into them and releasing an

enzyme called endolysin that punctures a hole in

the bacterium. The pressure builds and the

bacterium bursts releasing many more

bacteriophages.

Bacteriophages are not harmful to humans and as

bacteria evolve, bacteriophages do also. The good

news for humanity is that in order for bacteria to

become resistant to bacteriophages they would

have to give up their resistance to antibiotics.

The Future

Unfortunately, bacteriophage treatment is still

experimental and pharmaceutical companies are

reluctant to invest in a treatment without

approval. A worldwide pioneer clinical trial of

phage therapy was conducted between 2013 and

8

2017 and produced informative results. Hopefully

more research will be conducted into

bacteriophages because we do need a solution to

antibiotic resistance. We need one quickly.

A Bacterium

8

ANTIBIOTIC RESISTANCE

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!